Cannlabs (CANL) Osake Kurssi
Cannlabs Kurssi
Liikevaihto on kasvanut 80,1 % vuodessa viimeisten 6 vuoden aikana 1,36 M USD:een. Cannlabsn nettomarginaali on nyt −117,7 %, noussut −164,3 %:sta muutama vuosi sitten.
Cannlabs osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Cannlabs liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Cannlabs -osakkeesta
Cannlabs Inc is primarily active in the cannabis industry.
The main competitors of Cannlabs Inc in the market include other companies operating in the cannabis testing and analytics industry. Some notable competitors include SC Labs, EVIO Inc, Steep Hill, and ProVerde Laboratories. These companies offer similar services, providing quality control testing and laboratory analysis for cannabis products. Cannlabs Inc faces competition in terms of technological advancements, service quality, and client base in this rapidly growing industry.
The business model of Cannlabs Inc focuses on providing laboratory testing services for the cannabis industry. It offers comprehensive testing solutions to ensure the safety and quality of cannabis products, including testing for potency, contaminants, and pesticides. Cannlabs Inc aims to help cannabis businesses comply with regulatory standards and enhance consumer confidence in the industry. With its state-of-the-art facilities and expertise in cannabis testing, the company operates as a trusted third-party laboratory, providing accurate and reliable testing results. Cannlabs Inc plays a crucial role in promoting transparency and standardization within the rapidly evolving cannabis market.
Cannlabs Inc is a prominent company in the cannabis industry, specializing in cannabis testing and technology solutions. Founded in 2010, Cannlabs Inc has a rich history of providing accurate and reliable testing services to ensure the safety and potency of cannabis products. The company utilizes cutting-edge methodologies and advanced equipment to deliver precise results to its clients, including cultivators, manufacturers, and regulatory bodies. With a strong commitment to quality and compliance, Cannlabs Inc has established itself as a trusted name in the cannabis testing sector, offering innovative solutions to support the growth and development of the industry.
Cannlabs Inc has achieved several significant milestones. The company was the first independent testing laboratory to focus exclusively on cannabis. They have established themselves as a leader in providing accurate and reliable testing for cannabis products. Cannlabs Inc has also developed innovative testing methods and equipment, ensuring the safety and quality of marijuana products. Additionally, they have expanded their services to other states, becoming a trusted provider of cannabis testing solutions nationwide. With their commitment to excellence and expertise in the cannabis industry, Cannlabs Inc continues to make important strides in ensuring consumer safety and product quality.
Cannlabs Inc is primarily present in the United States.
Cannlabs Inc represents a commitment to providing reliable and accurate testing services to the cannabis industry. The company values integrity, transparency, and innovation in its operations. With its state-of-the-art testing facilities and experienced team, Cannlabs Inc ensures compliance with regulatory standards and promotes safety in the cannabis market. By offering comprehensive testing solutions, including potency, contaminants, and terpenes analysis, the company helps businesses and consumers make informed decisions. Cannlabs Inc is dedicated to advancing the understanding of cannabis through research and collaboration, further establishing its position as a trusted partner in the industry.
Nykyisellä valuuttakurssilla Cannlabs-osake noteerataan hintaan 0,00 EUR (0,00 USD).
CannLabs Inc is a company specializing in the analysis of cannabis products. Their business model includes various divisions and products that are all focused on supporting the legal cannabis industry. They offer analytical testing services for cannabis products, sell laboratory equipment needed for analysis, provide consultancy services for legal cannabis companies, and have a mobile testing unit called "Greenlight" that operates from a vehicle. The company's goal is to contribute to the development of the cannabis industry by focusing on the quality and safety of cannabis products, complying with industry regulations, and providing excellent customer service. The overall business model is aimed at professionally supporting the legalization of cannabis and meeting the needs of the industry with a focus on quality and safety.
Liikevaihtoa ei voida laskea Cannlabs:lle tällä hetkellä.
Voittoa ei voida laskea Cannlabs:lle tällä hetkellä.
P/E-suhdetta ei voida laskea Cannlabs:lle tällä hetkellä.
P/S-suhdetta ei voida laskea Cannlabs:lle tällä hetkellä.
Cannlabs:n Eulpool-laatuscore on 2/10.
Cannlabs:n ISIN on US13767T1025. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Cannlabs:n WKN on A1187M. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Cannlabs:n ticker on CANL. Tämä pörssinoteeraus käytetään Cannlabs-osakkeiden kauppaan pörssissä.
Cannlabs osake
Cannlabs vertaisryhmä
Cannlabs Ticker
Cannlabs FIGI
Kaikki tunnusluvut ja syvällinen analyysi Cannlabs:sta
Meidän osakeanalyysimme Cannlabs-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Cannlabs:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: